Kiniksa Pharmaceuticals L...

NASDAQ: KNSA · Real-Time Price · USD
33.36
0.08 (0.24%)
At close: Aug 15, 2025, 3:59 PM
33.38
0.06%
After-hours: Aug 15, 2025, 04:54 PM EDT

Kiniksa Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
4.79M -16.95M -43.19M -9.07M -10.23M 8.65M 14.08M -6.69M 231.26M 196.3M 183.36M 142.57M -112.07M -133.65M -157.92M -175.25M -188.54M -184.45M
Depreciation & Amortization
913K 1.57M 1.7M 1.53M 1.74M 1.91M 2.04M 2.4M 2.29M 2.34M 2.4M 2.47M 2.63M 2.7M 2.35M 2.25M 2.25M 2.12M
Stock-Based Compensation
32.75M 31.23M 30.69M 30.17M 29.13M 28.24M 27.15M 25.75M 25M 25.2M 25.12M 24.88M 25.04M 24.08M 25.17M 25.3M 24.66M 23.79M
Other Working Capital
39.88M 40.27M 46.81M 18.04M 5.76M 17.9M 19.13M -15.34M 9.73M -12.91M -2.01M 28.16M 9.32M 11.4M -2.02M -2.42M 2.29M 9.51M
Other Non-Cash Items
3.52M 23.71M 23.77M 22.93M 24.81M 5.28M 2.47M 2.31M 809K 2.05M 2.99M 3.28M 3.34M 3.28M 3.38M 3.5M 3.03M 2.45M
Deferred Income Tax
-1.17M 6.76M 8.13M -14.41M -487K -30.5M -33.79M -7.73M -203.86M -184.42M -185.5M -185.83M 25K 15K 25K 54K -11K 5.41M
Change in Working Capital
27.74M 17.83M 24.81M 311K 5.72M 9.67M 1.35M -18.64M -13.03M -3.09M -22.57M 11.13M -11.03M -19.44M 689K -4.46M 4.2M 5.81M
Operating Cash Flow
66.95M 44.03M 25.69M 11.24M 30.47M 21.55M 13.3M -2.6M 42.47M 38.39M 5.81M -1.5M -92.06M -123.02M -126.3M -148.6M -154.42M -144.86M
Capital Expenditures
-457K -292K -277K -140K -156K -190K -130K -42K -48K -129K -105K -388K -417K -361K -20.41M -20.22M -20.17M -20.11M
Cash Acquisitions
-25K n/a n/a 14.84M 27.12M -8.47M 29.43M 14.6M 2.33M 37.99M 91K 20.08M 20.09M 20M 40M 20M 20M 20M
Purchase of Investments
-206.27M -261.21M -202.01M -240.84M -239.44M -188.31M -204.93M -206.92M -171.16M -158.54M -135.86M -132.85M -115.52M -113.11M -157.25M -183.51M -393.72M -478.39M
Sales Maturities Of Investments
210.25M 222.08M 239.94M 198.44M 191.13M 222.39M 175.51M 149.63M 145.2M 135.3M 127.8M 117.7M 129.2M 174.55M 306.3M 451.05M 463.7M 431.1M
Other Investing Acitivies
25K -46.77M -21.16M -36M -48.29M 34.08M -29.43M -57.28M -25.96M -23.15M -7.97M 14.72M 43.56M 91.23M 93.95M 182.65M -14.9M -132.17M
Investing Cash Flow
3.52M -39.39M 37.67M -42.52M -48.44M 33.89M -29.56M -57.32M -26.01M -23.27M -8.08M -15.46M 13.35M 61.08M 128.63M 247.32M 49.81M -67.4M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-3.7M -5.01M -4.98M -4.67M -3.06M -2.17M -2.21M -2.04M -1.15M -752K -901K 5.08M 5.29M 5.32M 5.88M 6.55M 6.55M 6.55M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
25.59M 16.02M 17.25M 15.49M 7.74M 7.18M 3.7M 1.84M 755K 744K 1.23M 3.34M 777K 1.1M 1.21M 712K 2.63M 4.11M
Financial Cash Flow
22.3M 11.42M 12.27M 10.82M 4.68M 5.02M 1.5M 1.99M 1.8M 2.18M 2.52M 2.54M 4.86M 5.2M 5.88M 5.38M 149.1M 225.78M
Net Cash Flow
92.77M 16.05M 75.63M -20.45M -13.3M 60.46M -14.76M -57.93M 18.26M 17.29M 245K -14.42M -73.86M -56.74M 8.22M 104.1M 44.5M 13.52M
Free Cash Flow
66.49M 43.73M 25.41M 11.1M 30.31M 21.36M 13.17M -2.64M 42.42M 38.26M 5.7M -1.89M -92.48M -123.38M -146.71M -168.82M -174.59M -164.97M